DiaMedica Therapeutics Inc. (DMAC) Research & Development (2018 - 2019)
DiaMedica Therapeutics (DMAC) has 2 years of Research & Development data on record, last reported at $1.8 million in Q4 2019.
- For Q4 2019, Research & Development rose 24.19% year-over-year to $1.8 million; the TTM value through Dec 2019 reached $7.9 million, up 74.7%, while the annual FY2024 figure was $19.1 million, 45.36% up from the prior year.
- Research & Development reached $1.8 million in Q4 2019 per DMAC's latest filing, up from $1.6 million in the prior quarter.
- Across five years, Research & Development topped out at $2.6 million in Q1 2019 and bottomed at $791000.0 in Q1 2018.